See Tai Sandi
SEC CIK 2009350 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| LXEO | Lexeo Therapeutics, Inc. | Chief Development Off | 65.5K | — | $47.7K | 8 | 2025-01-07 | 2025-11-18 |
Most active insiders at LXEO, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Townsend Richard Nolan | CEO, Dir | — | $655.7K |
| 2 | Bhalla Narinder Pal | Chief Medical Off | — | $98.6K |
| 3 | Otero Jose Manuel | Chief Technical Off | — | $78.9K |
| 4 | Tamayo Louis Edward | CFO | — | $41.0K |
| 5 | See Tai Sandi | Chief Development Off | — | $38.4K |
| 6 | Robertson Jenny | CLO | — | $36.6K |
| 7 | Adler Eric | Chief Medical Off | — | $36.0K |
Transactions 8
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-11-20 | 2025-11-18 | LXEO | Lexeo Therapeutics, Inc. | See Tai Sandi | Chief Development Off | S - Sale | $9.27 | -386 | 65.5K | -0.6% | -$3,578 | |
| 2025-10-17 | 2025-10-15 | LXEO | Lexeo Therapeutics, Inc. | See Tai Sandi | Chief Development Off | A - Grant | $0.00 | +10.9K | 69.8K | +19% | $0 | |
| M | 2025-10-17 | 2025-10-17 | LXEO | Lexeo Therapeutics, Inc. | See Tai Sandi | Chief Development Off | S - Sale | $8.95 | -3,888 | 65.9K | -6% | -$34.8K |
| 2025-08-20 | 2025-08-18 | LXEO | Lexeo Therapeutics, Inc. | See Tai Sandi | Chief Development Off | S - Sale | $4.67 | -382 | 58.9K | -0.6% | -$1,784 | |
| 2025-05-20 | 2025-05-16 | LXEO | Lexeo Therapeutics, Inc. | See Tai Sandi | Chief Development Off | S - Sale | $2.77 | -367 | 59.2K | -0.6% | -$1,017 | |
| 2025-04-09 | 2025-03-14 | LXEO | Lexeo Therapeutics, Inc. | See Tai Sandi | Chief Development Off | A - Grant | $2.61 | +5,720 | 59.6K | +11% | +$14.9K | |
| 2025-02-21 | 2025-02-19 | LXEO | Lexeo Therapeutics, Inc. | See Tai Sandi | Chief Development Off | S - Sale | $4.41 | -1,486 | 53.9K | -3% | -$6,553 | |
| D | 2025-01-10 | 2025-01-07 | LXEO | Lexeo Therapeutics, Inc. | See Tai Sandi | Chief Development Off | A - Grant | $0.00 | +38.8K | 55.4K | +233% | $0 |
Purchase Sale Sale after option exercise All abbreviations